文献速递慢性肾脏病肾血管病与高血压

慢性肾脏病患者新发房颤与卒中风险:SCREAM项目

Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-07-20

本研究纳入116,184例无房颤史的慢性肾脏病(CKD)成人,随访期间12%发生新发房颤;新发房颤与卒中风险(HR 2.00;95%CI 1.88-2.14)和死亡风险(HR 1.76;95%CI 1.71-1.82)升高相关,竞争风险分析后卒中关联减弱但仍显著(sHR 1.49;95%CI 1.39-1.60)。

要点

  • CKD患者新发房颤后卒中风险增加约2倍,死亡风险增加约76%。
  • 房颤发病率随eGFR下降而升高,从29.4升至46.3/1000人年。
  • 竞争风险分析后房颤与卒中的关联减弱但仍显著。

核心结论

  • CKD患者发生新发房颤后卒中与死亡风险显著升高。

研究设计与样本

  • 回顾性队列研究,纳入2006-2011年瑞典斯德哥尔摩116,184例eGFR<60 ml/min per 1.73 m2且无既往房颤的CKD成人。
  • 新发房颤作为时变暴露,采用多变量Cox回归和竞争风险分析评估卒中与死亡风险。

主要发现

  • 平均随访3.9年(四分位距2.3-5.7年)期间,13,412例(12%)发生临床识别的新发房颤。
  • 房颤发病率随eGFR降低而升高:eGFR 45-60为29.4/1000人年,eGFR<30为46.3/1000人年。
  • 新发房颤后卒中发生率为53.8/1000人年(1388例),无房颤期为16.6/1000人年(6850例)。
  • 新发房颤后死亡发生率为205.1/1000人年(5592例),无房颤期为67.5/1000人年(28,613例)。
  • 调整后新发房颤与卒中(HR 2.00;95%CI 1.88-2.14)和死亡(HR 1.76;95%CI 1.71-1.82)风险升高相关。

关键数值与推荐

  • 卒中风险关联包括缺血性卒中(HR 2.11;95%CI 1.96-2.28)和颅内出血(HR 1.64;95%CI 1.42-1.90)。
  • 卒中风险在各eGFR分层间相似。
  • 竞争风险分析中卒中关联减弱但仍显著(sHR 1.49;95%CI 1.39-1.60)。

临床怎么用

  • CKD患者应重视新发房颤的监测与卒中风险评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Patients with CKD have a high risk of atrial fibrillation. Both CKD and atrial fibrillation are associated with higher risk of stroke and death. However, the effect of incident atrial fibrillation on stroke risk among patients with CKD is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our study included adults with CKD (eGFR<60 ml/min per 1.73 m2) without previously documented atrial fibrillation who had been in contact with health care in Stockholm, Sweden during 2006-2011. Incident atrial fibrillation was identified by administrative diagnostic codes in outpatient or inpatient care and treated as a time-updated exposure in the analysis of stroke and death risk. Stroke events and deaths were ascertained from regional and national registers with complete coverage. Covariates included demographics, comorbidities, therapeutic procedures, and medications. Multivariable Cox regression analysis and competing risk analysis (accounting for death) were used to estimate the association between incident atrial fibrillation and stroke. RESULTS: Among 116,184 adults with CKD, 13,412 (12%) developed clinically recognized atrial fibrillation during a mean follow-up of 3.9 years (interquartile range, 2.3-5.7 years). Incidence of atrial fibrillation increased across lower eGFR strata: from 29.4 to 46.3 atrial fibrillations per 1000 person-years in subjects with eGFR=45-60 and <30 ml/min per 1.73 m2, respectively; 1388 (53.8 per 1000 person-years) cases of stroke and 5592 (205.1 per 1000 person-years) deaths occurred after incident atrial fibrillation compared with 6850 (16.6 per 1000 person-years) cases of stroke and 28,613 (67.5 per 1000 person-years) deaths during periods without atrial fibrillation. After adjustment, incident atrial fibrillation was associated with higher risk of stroke (hazard ratio, 2.00; 95% confidence interval, 1.88 to 2.14) and death (hazard ratio, 1.76; 95% confidence interval, 1.71 to 1.82). This was attributed to both ischemic stroke (hazard ratio, 2.11; 95% confidence interval, 1.96 to 2.28) and intracranial bleeds (hazard ratio, 1.64; 95% confidence interval, 1.42 to 1.90). Stroke risk was similar across all eGFR strata. In competing risk analyses accounting for death, the association between incident atrial fibrillation and stroke was attenuated but remained higher (subhazard ratio, 1.49; 95% confidence interval, 1.39 to 1.60). CONCLUSIONS: Patients with CKD who develop atrial fibrillation are at higher risk of stroke and death.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Carrero JJ, Trevisan M, Sood MM, et al. Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project. Clin J Am Soc Nephrol. 2018. PMID: 30030271. doi:10.2215/CJN.04060318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。